Second quarter revenue of $3.7 million up 18% over prior year
Cost per pipeline addition cut in half over the last six months
Conference call begins at 4:30 p.m. Eastern time today
BOSTON (August 3, 2022) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and six months ended June 30, 2022. Read more.